Non-interventional post-authorization study of belzutifan in adult patients with von Hippel-Lindau disease-associated renal cell carcinoma, pancreatic neuroendocrine tumor and/or central nervous system hemangioblastoma (MK-6482-026)

19/01/2024
16/05/2025
EU PAS number:
EUPAS108114
Study
Ongoing
Subscribe
Download as PDF
Documents
Study protocol
Updated protocol

MK-6482-026-00-v4_Final-Redaction.pdf

First published: 05/05/2025
English (478.47 KB - PDF) View document
Study results
Study report
Other information
Study, other information

D1_PPLS_EUPAS 108114_for pub_12Mar2025_V1-0_MK-6482-026-04.pdf

English (142.91 KB - PDF) View document